ALPS Medical Breakthroughs ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBIO and other ETFs, options, and stocks.

About SBIO

SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. 

Index-Tracked
Bloomberg US 1000 TR USD
Index-TrackedBloomberg US 1000 TR USD
Category
Health
CategoryHealth
Number of holdings
110
Number of holdings110
Inception Date
Dec 30, 2014
Inception DateDec 30, 2014

SBIO Key Statistics

AUM
201.55M
AUM201.55M
Price-Earnings ratio
-15.18
Price-Earnings ratio-15.18
30-Day yield
-0.42
30-Day yield-0.42
Average volume
62.79K
Average volume62.79K
High today
High today
Low today
Low today
Open price
$65.67
Open price$65.67
Volume
0.00
Volume0.00
52 Week high
$69.34
52 Week high$69.34
52 Week low
$32.35
52 Week low$32.35
Expense ratio
0.50
Expense ratio0.50

Stock Snapshot

ALPS Medical Breakthroughs ETF(SBIO) stock is priced at $63.80, giving the company a market capitalization of 202.18M. It carries a P/E multiple of -15.18.

ALPS Medical Breakthroughs ETF(SBIO) stock opened on 2026-07-21 at $65.67. The price climbed to — and dipped to —.

The ALPS Medical Breakthroughs ETF(SBIO)'s current trading volume is 0, compared to an average daily volume of 62.79K.

In the last year, ALPS Medical Breakthroughs ETF(SBIO) shares hit a 52-week high of $69.34 and a 52-week low of $32.35.

In the last year, ALPS Medical Breakthroughs ETF(SBIO) shares hit a 52-week high of $69.34 and a 52-week low of $32.35.

Average Annual Return

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.